A Premier Centre for Cutting Edge Cancer Research.
A dynamic research institute encompassing basic and translational studies, devoted to understanding the pathogenesis and treatment of cancer
CSI Research Fellow Awarded at the 17th International Myeloma Workshop (IMW)
Congratulations to Dr. Teoh Phaik Ju, research fellow from Prof. Chng Wee Joo’s lab who received the “IMS Award for Exemplary Abstract” award.
Read More
(Nat Commun, Sep 2019)
c-Met activation leads to the establishment of a TGFB-receptor regulatory network in bladder cancer progression.
Read More
(Theranostics, Aug 2019)
CAV1 – GLUT3 signaling is important for cellular energy and can be targeted by Atorvastatin in Non-Small Cell Lung Cancer.
Read More
(J Hepatol, Sep 2019)
Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/B-catenin-driven hepatocellular carcinoma.
Read More
(Gastroenterology, Aug 2019)
New High-throughput Screen Identifies Compounds That Reduce Viability Specifically In Liver Cancer Cells That Express High Levels of SALL4 by Inhibiting Oxidative Phosphorylation.
Read More
CSI Deputy Director, Prof. Goh Boon Cher, Receives National Outstanding Clinician Scientist Award
Congratulations to Prof. Goh on his remarkable achievement at this year's National Medical Excellence Awards (NMEA) ceremony!
Read More
Giving to CSI
You can help us to shape the next generation of innovative cancer research
Frontiers in Cancer Science 2019
FCS 2019 invites scientists, doctors, students and other delegates engaging in
scientific research related to cancer to Singapore’s preferred cancer conference.
